<DOC>
	<DOCNO>NCT01423240</DOCNO>
	<brief_summary>Lurasidone HCl compound candidate treatment major depressive mix features.This clinical study design test well Lurasidone work treat major depressive disorder mixed feature .</brief_summary>
	<brief_title>Major Depressive Disorder With Mixed Features</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>Subject provide write informed consent willing able comply protocol opinion Investigator . Subject 18 75 year age , inclusive . Subject MDD ( diagnose DSMIVTR , confirm Structured Clinical Interview DSMIV Disorders Clinical Trial version [ SCIDCT ] ) . Subject currently experience major depressive episode ( diagnosed DSMIVTR ; least 2 week duration ) AND two three follow manic symptom occur day least last 2 week ( confirm SCIDCT modify Study D1050305 ) : Elevated , expansive mood Inflated selfesteem grandiosity More talkative usual pressure keep talk Flight idea subjective experience thought race Increase energy goaldirected activity ( either socially , work school , sexually ) Increased excessive involvement activity high potential painful consequence ( e.g. , engage unrestrained buying spree , sexual indiscretion , foolish business investment ) Decreased need sleep ( feel rest despite sleep less usual ; contrast insomnia ) Subject rateradministered MontgomeryAsberg Depression Rating Scale ( MADRS ) total score ≥ 26 screening rateradministered selfrated ( administer computer ) MADRS total score ≥ 26 baseline . Subject Axis I Axis II diagnosis MDD primary focus treatment within 3 month prior screen Subject answer `` yes '' `` Suicidal Ideation '' Item 4 5 CSSRS ( time evaluation ) screen baseline visit . Subject attempt suicide within past 3 month . Subject lifetime history bipolar I manic mixed manic episode . Subject abnormal laboratory parameter screen indicates clinically significant medical condition determine Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Depression</keyword>
	<keyword>Lurasidone</keyword>
	<keyword>Latuda</keyword>
</DOC>